Claude Science launches as a dedicated AI research app for drug discovery and biology
Anthropic has unveiled Claude Science, a specialized AI application designed specifically for scientific research in drug discovery and biology. This new platform represents Anthropic's first major vertical-specific AI tool, targeting the pharmaceutical and life sciences industries with advanced capabilities tailored to scientific workflows. Claude Science integrates specialized knowledge bases for molecular biology, chemistry, and medical research, enabling researchers to accelerate their work through AI-powered analysis, hypothesis generation, and experimental design assistance. The app features tools for analyzing complex biological data, suggesting drug candidates, and predicting molecular interactions with unprecedented accuracy. Early beta testers have reported significant reductions in research time and improved discovery rates, with some pharmaceutical companies reporting up to 40% faster identification of promising compounds. The launch comes amid growing interest in AI applications for healthcare and scientific research, with major tech companies racing to develop specialized tools for these high-impact fields. Claude Science maintains Anthropic's commitment to safety and reliability while providing domain-specific capabilities that general-purpose AI models cannot match.